Group Health Research Institute (GHRI) is the research arm of Group Health Cooperative, a Seattle-based, consumer-governed, nonprofit health care system that coordinates health care and coverage for more than 600,000 people.
Since 1983, the Institute has conducted nonproprietary public-interest research on preventing, diagnosing, and treating major health problems.
About 60 health scientists—including physicians, epidemiologists, biostatisticians, psychologists, economists, and health services researchers. Most faculty members have a joint appointment at the University of Washington. GHRI also employs about 300 other staff members.
In 2014, GHRI’s external revenue exceeded $46 million.
Federal agencies (NIH, CDC, AHRQ, etc.) = 70% of GHRI's annual budget.
Grants and contracts from foundations (Robert Wood Johnson, Paul B. Allen Family Foundation, Group Health Foundation, etc.) = 12%.
Other (includes PCORI, state, and industry) = 11%.
Group Health = 7%.
GHRI belongs to several national consortia, including the HMO Research Network, which has data on about 12 million lives. Others include the Cancer Research Network, and the Breast Cancer Surveillance Consortium. GHRI also hosts one of eight federally funded Vaccine and Treatment Evaluation Units.
The MacColl Center for Health Care Innovation and the Center for Community Health and Evaluation are part of GHRI.
In 2014, GHRI managed a total of 307 active grants and published 452 articles in peer-reviewed medical journals.